Nuvilex Appoints CEO and President of Austrianova to Scientific Advisory Board: Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that its subsidiary, Medical Marijuana Sciences, Inc., has appointed Brian Salmons, Ph.D., CEO and President of Nuvilexs partner Austrianova, to its Scientific Advisory Board. Dr. Salmons, together with Professor Dr. Walter H. Günzburg, invented and developed the live-cell encapsulation technology now known as Cell-in-a-Box™ which has been licensed by Nuvilex for the development of treatments for cancer and diabetes. It is expected that, given his expertise in this and other aspects of the development of disease treatments, Dr. Salmons will play a pivotal role as Medical Marijuana Sciences goes forward with its cannabis-based cancer treatments. stockwatch/News/Item.aspx?bid=U-z10072083-U%3aNVLX-20140311&symbol=NVLX®ion=U
Posted on: Tue, 11 Mar 2014 13:18:54 +0000